Chronic Atrial and Ventricular Pacing in the Mouse: Application to Model Cardiac Dyssynchrony and Resynchronization in Heart Failure

Background: The mouse is the most widely used mammal in experimental biology. Although many clinically relevant in vivo cardiac stressors are used, one that has eluded translation is long-term cardiac pacing. Here, we present the first method to chronically simulate and simultaneously record cardiac electrical activity in conscious mobile mice. We then apply it to study right ventricular pacing induced electromechanical dyssynchrony and its reversal (resynchronization). Methods and Results: The method includes a custom implantable bipolar stimulation and recording lead and flexible external conduit and electrical micro-commutator linked to a pulse generator/recorder. This achieved continuous pacing for at least 1 month in 77% of implants. Mice were then subjected to cardiac ischemia/reperfusion injury to depress heart function, followed by 4 weeks pacing at the right ventricle (dyssynchrony), right atrium (synchrony), or for 2 weeks right ventricle and then 2 weeks normal sinus (resynchronization). Right ventricular pacing–induced dyssynchrony substantially reduced heart and myocyte function compared with the other groups, increased gene expression heterogeneity (>10 fold) comparing septum to lateral walls, and enhanced growth and metabolic kinase activity in the late-contracting lateral wall. This was ameliorated by restoring contractile synchronization. Conclusions: The new method to chronically pace conscious mice yields stable atrial and ventricular capture and a means to dissect basic mechanisms of electromechanical physiology and therapy. The data on dyssynchrony and resynchronization in ischemia/reperfusion hearts is the most comprehensive to date in ischemic heart disease, and its similarities to nonischemic canine results support the translational utility of the mouse.

[1]  R. Weissleder,et al.  A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse , 2018, Circulation research.

[2]  D. Kass,et al.  Cellular and Molecular Aspects of Dyssynchrony and Resynchronization. , 2017, Heart failure clinics.

[3]  Theodore P Abraham,et al.  Pacemaker-induced transient asynchrony suppresses heart failure progression , 2015, Science Translational Medicine.

[4]  G. Lalani,et al.  Cardiac resynchronisation therapy in patients with chronic heart failure , 2015, Heart.

[5]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[6]  C. Redwood,et al.  New mechanisms and concepts for cardiac-resynchronization therapy. , 2014, The New England journal of medicine.

[7]  D. Kass,et al.  Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP–Protein Kinase G Modulation , 2014, Circulation research.

[8]  D. Kass,et al.  Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β. , 2014, The Journal of clinical investigation.

[9]  Igor R. Efimov,et al.  A Fully Implantable Pacemaker for the Mouse: From Battery to Wireless Power , 2013, PloS one.

[10]  D. Kass,et al.  Subcellular Structures and Function of Myocytes Impaired During Heart Failure Are Restored by Cardiac Resynchronization Therapy , 2012, Circulation research.

[11]  D. Kass,et al.  Redox Regulation of Mitochondrial ATP SynthaseNovelty and Significance , 2011 .

[12]  Brian O'Rourke,et al.  Redox Regulation of Mitochondrial ATP Synthase: Implications for Cardiac Resynchronization Therapy , 2011, Circulation Research.

[13]  D. Kass,et al.  Gαs-Biased β2-Adrenergic Receptor Signaling from Restoring Synchronous Contraction in the Failing Heart , 2011, Science Translational Medicine.

[14]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[15]  D. Kass,et al.  Mechanisms of Enhanced &bgr;-Adrenergic Reserve From Cardiac Resynchronization Therapy , 2009, Circulation.

[16]  Brian O'Rourke,et al.  Electrophysiological Consequences of Dyssynchronous Heart Failure and Its Restoration by Resynchronization Therapy , 2009, Circulation.

[17]  D. Kass,et al.  Cardiac Resynchronization Therapy Corrects Dyssynchrony-Induced Regional Gene Expression Changes on a Genomic Level , 2008, Circulation: Cardiovascular Genetics.

[18]  D. Kass,et al.  Reversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization , 2008, Circulation.

[19]  W. Wijns,et al.  Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. , 2008, Journal of Cardiac Failure.

[20]  W. Wijns,et al.  Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. , 2008, Journal of the American College of Cardiology.

[21]  S. Viatchenko‐Karpinski,et al.  Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy. , 2007, Life sciences.

[22]  D. Kass,et al.  Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse. , 2006, Physiological genomics.

[23]  Christophe Leclercq,et al.  Regional Alterations in Protein Expression in the Dyssynchronous Failing Heart , 2003, Circulation.

[24]  Paolo Rizzon,et al.  Clinical Application of Echocardiographic Findings Cardiac Resynchronization Therapy Tailored by Echocardiographic Evaluation of Ventricular Asynchrony , 2016 .

[25]  Gregory S. Nelson,et al.  Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block , 2000, Circulation.

[26]  C. H. Chen,et al.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. , 1999, Circulation.